High affinity soluble PD-1 ectodomains and related decoy constructs are conceptually well suited for vectorized or matrix-anchored formats that concentrate checkpoint blockade within the tumor microenvironment, although this remains largely at the preclinical or theoretical stage for PD-1/PD-L1 (16). The gene discussed is PDCD1; the disease is neoplasm.